Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration. The core of our innovation is the precise temperature control of the macula during non-damaging laser treatments; a potential game changer in the practise of how major retinal diseases, with over USD 400B direct health care costs, are being treated in the future.
Our innovations allow clinicians to perform previously infeasible laser therapy and potentially help millions of people to retain their vision.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Helsinki, Uusimaa 00290, Fi
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- maculaser.com
- Keywords
- age-related macular degeneration, medical technology, ophthalmology, retina, diabetic retinopathy.
- HQ
- Helsinki, Uusimaa
Maculaser Ltd Questions
Maculaser Ltd's website is maculaser.com
Maculaser Ltd's LinkedIn profile is https://fi.linkedin.com/company/maculaser
Maculaser Ltd has
5 employees.
View email and phone details for 5
employees at Maculaser Ltd.
Maculaser Ltd's industry is
Medical Equipment Manufacturing
Maculaser Ltd's top competitors are
Beyeonics™ Vision,
Ciliatech - Glaucoma Innovators,
Zilia,
Recornea,
Epion Therapeutics,
Bionic Vision Technologies,
Istar Medical,
Azalea Vision,
Eyetronic,
Avisi Technologies.
Maculaser Ltd's categories are Medical Equipment Manufacturing
Maculaser Ltd's founding year is 2020
